Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 11.99 -1.40% -0.17
FLXN closed down 1.4 percent on Friday, July 10, 2020, on 33 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical FLXN trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Fell Below 20 DMA Bearish -1.40%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.40%
Outside Day Range Expansion -1.40%
Crossed Above 20 DMA Bullish -4.08%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.08%
Fell Below 20 DMA Bearish -2.60%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.60%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Chemistry Pain Organic Compounds Organic Chemistry Osteoarthritis Arthritis Glucocorticoids Organofluorides Skeletal Disorders

Is FLXN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.98
52 Week Low 5.01
Average Volume 944,488
200-Day Moving Average 14.06
50-Day Moving Average 11.37
20-Day Moving Average 12.54
10-Day Moving Average 12.67
Average True Range 0.76
ADX 12.47
+DI 20.04
-DI 20.80
Chandelier Exit (Long, 3 ATRs ) 11.30
Chandelier Exit (Short, 3 ATRs ) 12.95
Upper Bollinger Band 13.63
Lower Bollinger Band 11.45
Percent B (%b) 0.25
BandWidth 17.35
MACD Line 0.27
MACD Signal Line 0.45
MACD Histogram -0.1716
Fundamentals Value
Market Cap 382.54 Million
Num Shares 31.9 Million
EPS -3.11
Price-to-Earnings (P/E) Ratio -3.86
Price-to-Sales 0.00
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.49
Resistance 3 (R3) 12.50 12.36 12.40
Resistance 2 (R2) 12.36 12.23 12.35 12.37
Resistance 1 (R1) 12.17 12.15 12.10 12.16 12.35
Pivot Point 12.03 12.03 11.99 12.02 12.03
Support 1 (S1) 11.84 11.90 11.77 11.83 11.63
Support 2 (S2) 11.70 11.82 11.69 11.61
Support 3 (S3) 11.51 11.70 11.58
Support 4 (S4) 11.50